Clinical Trial

LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia

Study acronym: LLM-CoManage
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.
Protocol Amendment History 1 change
notable Enrollment increased: 6000 -> 6800 participants 2026-05-14
Trial Details
NCT Number NCT07350486
Lead Sponsor First Hospital of China Medical University
Collaborators: Beijing Chao Yang Hospital, Zhejiang University, Shandong Provincial Hospital, Cangzhou Central Hospital
Conditions Hypertension, Diabetes, Dyslipidemia
Enrollment 6,800 participants
Start Date 2026-06-15
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-13